Table 3:

Logistic regression for the VITdAL-ICU cohort. The comparison group was those patients who developed persistent critical illness.

Compared to those who developed Persistent Critical Illness
	Alive and discharged before Persistent Critical Illness		Dead before onset of Persistent Critical Illness
	RRR	95% CI	RRR	95%CI
25-hydroxyvitamin D (per ng/mL)	1.03	0.98–1.08	0.96	0.89–1.04
Age (per year)	1.01	1.00–1.03	1.03	1.01–1.06
SAPs II (per point)	1.00	0.99–1.01	1.01	0.99–1.02
Charlson Comorbidity Index (per point)	0.93	0.84–1.04	1.02	0.88–1.18
TISS-28 (per point)	0.92	0.89–0.95	1.09	1.03–1.14
Treatment
Yes (vs Placebo)	1.19	0.79–1.80	1.34	0.72–2.52
ICU type (vs Medical ICU)
Neuro	1.02	0.53–1.99	0.53	0.20–1.43
Cardiosurgical	0.73	0.40–1.32	0.14	0.06–0.33
Mixed Surgical ICU	0.53	0.28–0.99	0.17	0.07–0.41

SAPS II: Simplified acute physiology score; TISS-28: Therapeutic Intervention Score; ICU: Intensive care unit; RRR: relative risk ratio